491 – 500 of 1570
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Valproate in combination with rituximab and CHOP as first-line therapy in diffuse large B-cell lymphoma (VALFRID)
(
- Contribution to journal › Article
-
Mark
Roles of PDZ-dependent Interactions and N-glycosylation in G Protein-coupled Estrogen Receptor 1 (GPER1)/GPR30-mediated Stimulation of ERK1/2 Activity
(
- Contribution to journal › Published meeting abstract
-
Mark
Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)
(
- Contribution to journal › Article
-
Mark
Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Functional Connectivity Changes in Systemic Lupus Erythematosus : A Resting-State Study
(
- Contribution to journal › Article
-
Mark
DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Comment on : Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature
(
- Contribution to journal › Letter
-
Mark
The risk of clinically diagnosed gout by serum urate levels : Results from 30 years follow-up of the Malmö preventive project cohort in southern Sweden
(
- Contribution to journal › Article
-
Mark
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
(
- Contribution to journal › Article